The potential of Beclin 1 as a therapeutic target for the treatment of breast cancer.

about

Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells.Apigenin in cancer therapy: anti-cancer effects and mechanisms of action.Allyl Isothiocyanate Exhibits No Anticancer Activity in MDA-MB-231 Breast Cancer Cells.

P2860

Q41619667-A7D356DD-D3D0-44BB-B2C3-347CCD9DA25C Q42371219-7B13946D-AD0D-4428-83E1-39FA7AACC240 Q47233186-4D0EFF9B-A074-4E80-A952-13B38F5FD107

P2860

The potential of Beclin 1 as a therapeutic target for the treatment of breast cancer.

Item

http://www.wikidata.org/entity/Q38584313

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

The potential of Beclin 1 as a therapeutic target for the treatment of breast cancer.

@en

type

Item

label

The potential of Beclin 1 as a therapeutic target for the treatment of breast cancer.

@en

prefLabel

The potential of Beclin 1 as a therapeutic target for the treatment of breast cancer.

@en

P1476

The potential of Beclin 1 as a therapeutic target for the treatment of breast cancer

@en

P2093

Yoon Yang Jung

http://www.w3.org/2001/XMLSchema#string

Yu Kyung Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Endogenous HMGB1 regulates autophagy

Parkin mono-ubiquitinates Bcl-2 and regulates autophagy

PtdIns(3)P controls cytokinesis through KIF13A-mediated recruitment of FYVE-CENT to the midbody

p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy

DAP-kinase-mediated phosphorylation on the BH3 domain of beclin 1 promotes dissociation of beclin 1 from Bcl-XL and induction of autophagy

Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13

A phosphatidylinositol 3-kinase class III sub-complex containing VPS15, VPS34, Beclin 1, UVRAG and BIF-1 regulates cytokinesis and degradative endocytic traffic

Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network

Use of chromatin immunoprecipitation to clone novel E2F target promoters

Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor

P304

167-178

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728222.2016.1085971

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ja Seung Koo

P577

2015-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26357854

http://www.w3.org/2001/XMLSchema#string

The potential of Beclin 1 as a therapeutic target for the treatment of breast cancer.

about

P2860

P2860

The potential of Beclin 1 as a therapeutic target for the treatment of breast cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698